A clinical study on the usefulness of combination tablet of candesartan and hydrochlorothiazide in hypertensive patients

A clinical study on the usefulness of combination tablet of candesartan and hydrochlorothiazide in hypertensive patients - A clinical study on the usefulness of combination tablet of candesartan and hydrochlorothiazide in hypertensive patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005886

Enrollment

Registered

2011-06-30

Start date

2011-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensive patients

Interventions

combination tablet of candesartan and hydrochlorothiazide

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Uncontrolled hypertensive patients BP >= 130/80mmHg Outpatients

Exclusion criteria

Exclusion criteria: Serum creatinine > 2.5 mg/dL Liver damage Pregnant or possibly pregnant patients Lactation period Nephrotic syndrome

Design outcomes

Primary

Measure	Time frame
Change of urinary angiotensinogen and blood pressure	—

Secondary

Measure	Time frame
Change of serum uric acid, BNP, and urinary albumin excretion	—

Countries

Japan

Contacts

Public ContactIwao Ohno MD

Jikei University School of Medicine Division of Kidney and Hypertension, Department of Internal Medicine

i-ohno@jikei.ac.jp03-3433-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026